A Phase I Study of Temozolomide (Temodar®) in Pediatric Patients with Relapsed or Refractory Leukemia—A Children's Oncology Group Study.

Autor: Horton, Terzah M., Dolan, Eileen *, Hegde, Madhuri *, Berg, Stacey L. *, Adamson, Peter *, Blaney, Susan M. *
Zdroj: In Blood 16 November 2005 106(11):4455-4455
Databáze: ScienceDirect